Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration
International Journal of Angiology · 01.03.2026 · 35 (01) · 064-070
DOI: 10.1055/a-2640-0775 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Angiology, erschienen am 01.03.2026. Verfasst von Mehmet Işık und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study aimed to analyze the survival time of patients who underwent thoracic endovascular aortic replacement (TEVAR) due to acute type 3 aortic dissection and to investigate comorbid conditions and dissection characteristics that affect survival time. Between 2013 and 2023, 94 patients who underwent TEVAR for type 3 dissection were retrospectively investigated. Survival time and factors affecting this time (comorbidity and dissection characteristics) were analyzed. The most common comorbidities were hypertension (88%). There was no significant difference between the demographic data of surviving and deceased patients. During the follow-up period, 57% of the patients survived, and 43% of the patients died. The mean survival time after TEVAR was 20.1 (0–108) months among patients who died and 47.7 (2–120) months for patients who lived. The mean number of comorbidities was 2.13 in patients who died and 2.25 in patients who survived. Survival distribution according to the type of interventional procedure was 50% for partial closure of the subclavian artery, 38.1% for complete closure, and 66.2% for closure starting from the distal subclavian artery (p = 0.06). Survival rate was significantly higher in patients who underwent reintervention (p = 0.005). Mortality was 9.5% in the early period, 25.5% in the first year, 29.7% in the second year, 34% in the third year, and 39.3% in the first 5 years. In our study, the survival rate was higher in patients who were followed regularly, and reintervention was applied when necessary. Therefore, we believe that undetected or untreated complications after TEVAR, rather than comorbid conditions, negatively affect survival more.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye.
ORCID-Profile: Mehmet Işık, Yalçın Günerhan, Ömer Tanyeli, Serkan Yıldırım, Ali Demiray
Zitieren
APA
Işık, M., Günerhan, Y., Tanyeli, Ö., Yıldırım, S., & Demiray, A. (2026). Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration. International Journal of Angiology, 35(01), 064-070. https://doi.org/10.1055/a-2640-0775
Vancouver
Işık M, Günerhan Y, Tanyeli Ö, Yıldırım S, Demiray A. Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration. International Journal of Angiology. 2026;35(01):064-070. doi:10.1055/a-2640-0775
BibTeX
@article{Ik2026,
author = {Işık, Mehmet and Günerhan, Yalçın and Tanyeli, Ömer and Yıldırım, Serkan and Demiray, Ali},
title = {Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration},
journal = {International Journal of Angiology},
year = {2026},
volume = {35},
number = {01},
pages = {064--070},
doi = {10.1055/a-2640-0775}
}
EUVIMED